Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Diphtheria01:28

Diphtheria

169
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
169
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

60
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
60
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

9
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
9
Teratogenicity01:07

Teratogenicity

4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Development of Immunocompetence01:22

Development of Immunocompetence

1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Detection of <i>Cryptosporidium hominis</i> by clinical metagenomics in stool samples from an outbreak of diarrhoea among British military personnel in Kenya.

BMJ military health·2026
Same author

Severe anaemia and invasive bacterial infections in Kenyan children: a 26-year hospital surveillance observational study.

The Lancet. Global health·2026
Same author

Dengue and chikungunya vaccination in military populations, a comment on Bogacka et al.

Travel medicine and infectious disease·2026
Same author

Carrying the weight in silence: lived realities of epilepsy caregivers in Shai Osudoku and Ningo Prampram.

Epilepsy & behavior : E&B·2026
Same author

Efficacy and Safety of Newer Antibiotics Versus Generic Antibiotics for Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

NeuroDev: etiology and experience of neurodevelopmental disorders in Kenya and South Africa.

medRxiv : the preprint server for health sciences·2026

Video Experimental Relacionado

Updated: Apr 25, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

5.5K

Tétanos materno y neonatal.

C Louise Thwaites1, Nicholas J Beeching2, Charles R Newton3

  • 1Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.

Lancet (London, England)
|August 24, 2014
PubMed
Resumen
Este resumen es generado por máquina.

El tétanos materno y neonatal sigue siendo un asesino prevenible, causando miles de muertes al año. La vacunación continua y la mejora de la salud pública son cruciales para los esfuerzos de eliminación global.

Más Videos Relacionados

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
04:18

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

Published on: October 10, 2025

722
A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

3.1K

Videos de Experimentos Relacionados

Last Updated: Apr 25, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

5.5K
Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
04:18

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

Published on: October 10, 2025

722
A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

3.1K

Área de la Ciencia:

  • Salud Pública La salud pública.
  • Enfermedades infecciosas Enfermedades infecciosas.
  • La pediatría es la medicina de los niños.

Sus antecedentes:

  • El tétanos materno y neonatal representan causas significativas, pero prevenibles, de mortalidad en las naciones en desarrollo.
  • Las altas tasas de mortalidad y las opciones limitadas de tratamiento exacerban el impacto de estas enfermedades.
  • La Iniciativa de Eliminación del Tétanos Materno y Neonatal de la Organización Mundial de la Salud ha impulsado el progreso, pero persisten los desafíos.

Objetivo del estudio:

  • Para resumir el progreso y los desafíos en curso en el esfuerzo mundial para eliminar el tétanos materno y neonatal.
  • Para resaltar las estrategias clave empleadas en las iniciativas de eliminación del tétanos.
  • Para subrayar los obstáculos restantes y las necesidades futuras para la erradicación completa de la enfermedad.

Principales métodos:

  • Revisión de las iniciativas globales e informes de progreso en la eliminación del tétanos materno y neonatal.
  • Análisis de los factores que contribuyen a la incidencia de la enfermedad y la mortalidad.
  • Identificación de los países que aún enfrentan desafíos en la eliminación del tétanos.

Principales resultados:

  • Se ha logrado un progreso sustancial en la reducción de la incidencia del tétanos materno y neonatal a través de la vacunación y la mejora de la higiene.
  • Se estima que 58.000 recién nacidos y un número desconocido de madres aún mueren anualmente de tétanos.
  • En junio de 2014, 24 países aún no habían eliminado el tétanos materno y neonatal.

Conclusiones:

  • Los programas de vacunación sostenidos y la mejora de la infraestructura de salud pública son esenciales para mantener la eliminación.
  • Los enfoques específicos en áreas de alto riesgo siguen siendo críticos.
  • Es necesario un compromiso global continuo para lograr la erradicación completa del tétanos materno y neonatal.